搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

  1. 首頁
  2. 試劑盒
  3. 酶聯(lián)免疫試劑盒
  4. Human Prolactin Inducible Protein(PIP)ELISA Kit

Human Prolactin Inducible Protein(PIP)ELISA Kit

  • 中文名稱：
    人催乳素誘導(dǎo)蛋白(PIP)酶聯(lián)免疫試劑盒
  • 貨號：
    CSB-E15980h
  • 規(guī)格：
    96T/48T
  • 價格：
    ￥3600/￥2500
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    人催乳素誘導(dǎo)蛋白(PIP)酶聯(lián)免疫試劑盒（CSB-E15980h）為雙抗夾心法ELISA試劑盒，定量檢測血清、血漿、組織勻漿樣本中的PIP含量。人催乳素誘導(dǎo)蛋白（PIP）是一種與催乳素相關(guān)的蛋白，主要作用是促進泌乳過程。其研究機制涉及下丘腦-垂體軸的調(diào)節(jié)，通過影響乳腺發(fā)育、乳汁分泌和維持乳汁分泌等環(huán)節(jié)，對泌乳障礙的婦女具有臨床應(yīng)用價值。試劑盒檢測范圍為0.055 ng/ml- 40ng/ml，靈敏度為0.055 ng/ml。適用于乳腺癌機制研究、激素調(diào)控通路分析、細胞增殖與免疫調(diào)節(jié)實驗等科研領(lǐng)域。本品僅用于科研，不用于臨床診斷，產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說明書。
  • 別名：
    BRST-2 ELISA Kit; BRST2 ELISA Kit; GCDFP-15 ELISA Kit; GCDGP15 ELISA Kit; gp17 ELISA Kit; GPIP4 ELISA Kit; Gross cystic disease fluid protein 15 ELISA Kit; PIP ELISA Kit; PIP_HUMAN ELISA Kit; Prolactin induced protein ELISA Kit; Prolactin inducible protein precursor ELISA Kit; Prolactin-induced protein ELISA Kit; Prolactin-inducible protein ELISA Kit; SABP ELISA Kit; Secretory actin binding protein ELISA Kit; Secretory actin-binding protein ELISA Kit
  • 縮寫：
    PIP
  • Uniprot No.：
  • 種屬：
    Homo sapiens (Human)
  • 樣本類型：
    serum, plasma, tissue homogenates
  • 靈敏度：
    0.05 ng/ml
  • 反應(yīng)時間：
    1-5h
  • 樣本體積：
    50-100ul
  • 檢測波長：
    450 nm
  • 研究領(lǐng)域：
    Others
  • 測定原理：
    quantitative
  • 測定方法：
    Sandwich
  • 數(shù)據(jù)處理：
  • 貨期：
    3-5 working days

產(chǎn)品評價

靶點詳情

  • 基因功能參考文獻：
    1. Unusual N-type glycosylation of salivary prolactin-inducible protein (PIP): multiple Lewis(Y) epitopes generate highly-fucosylated glycan structures. PMID: 29858715
    2. that GATA3 is a very sensitive marker for primary genital extramammary Paget diseases and is more sensitive than gross cystic disease fluid protein 15 PMID: 28693610
    3. monoclonal antibodies to GATA-3 are very sensitive reagents for the identification of breast CA, surpassing antibodies to GCDFP-15 and mammaglobin A, and offer a significant improvement in identifying TNBCs PMID: 26447897
    4. good coincidence was observed between primary and metastatic tumor GATA3 expression (kappa value = 0.826 >0.75) as compared with the coincidence of GCDFP15 (kappa value =0.492 <0.75) and mammaglobin (kappa value =0.593 <0.75) PMID: 28038704
    5. High expression of GCDFP-15 is associated with molecular apocrine breast cancer. PMID: 26711786
    6. While highly expressed under pathological conditions of the mammary gland, including breast cancers, PIP is expressed in very few other cancers. Although the function of PIP is not well elucidated, numerous studies suggest that its primary role may be related to host defense and immune modulation. Studies in Pip null mice suggest that PIP may play a similar immune-regulatory role in breast cancer. [Review] PMID: 27602994
    7. novel marker GATA3 stains a significantly higher proportion of both primary and metastatic breast carcinomas than GCDFP15 or mammaglobin with stronger and more diffuse staining, helpful in cases with small tissue samples PMID: 25906123
    8. In summary, this study suggests that PIP expression regulates the process of cell adhesion in breast cancer. PMID: 26585492
    9. GCDFP15 in stratum corneum is a potential marker for dysregulated sweating in atopic dermatitis. PMID: 25919462
    10. The commonly used breast carcinoma biomarkers vary in their prognostic implications. GCDFP-15 independently indicated a favourable prognosis. GATA-3 and MGB were not associated with outcome. PMID: 25425335
    11. Data indicate the potential role of Gross cystic disease fluid protein-15/prolactin-inducible protein (GCDFP-15/PIP) as a biomarker for keratoconus (KC)disease. PMID: 25405607
    12. Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer. PMID: 22817771
    13. GCDFP-15 expression is higher in tumors with favorable prognostic features. GCDFP-15 expression is further a frequent feature of androgen receptor positive tumors and the molecular apocrine subtype. PMID: 25070172
    14. PIP is a breast cancer-related protein that is expressed in a majority of breast tumors and has a significant function in the biology of this disease. [review] PMID: 25472539
    15. we found that HER2 or GCDFP15 protein overexpression is a sensitive and specific tool to differentiate MA from BL in the context of ER negative tumors. PMID: 23663520
    16. The roles of PIP in the related T47D breast cancer cell line, were investigated. PMID: 23755096
    17. PIP is required for cell cycle progression in breast cancer and provides a rationale for exploring PIP inhibition as a therapeutic approach in breast cancer that can potentially target microtubule polymerization. PMID: 24862759
    18. Report GCDFP15 expression in metastatic basal-like triple negative breast carcinomas. PMID: 24272937
    19. AZGP1 and PIP were found in significantly lower levels in invasive breast tissue. PMID: 24114735
    20. GCDFP-15 was associated significantly with a breast cancer profile of good prognosis tumors. PMID: 23332923
    21. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. PMID: 22963676
    22. Interaction analysis identifies semenogelin I fragments as new binding partners of PIP in human seminal plasma PMID: 23085372
    23. GCDFP-15 alone is not a useful marker to detect the metastasis of basaloid type breast cancers. PMID: 23011826
    24. expression was down-regulated in azoospermia, indicating that PIP may be a plausible marker of azoospermia PMID: 22724438
    25. The first report of native human serum albumin (HSA)-PIP complex formation in seminal plasma. PMID: 22209935
    26. abnormal development of the prepuce in hypospadias is associated with variation in PIP expression PMID: 21883842
    27. Data suggest that Runx2 controls a positive feedback loop between androgen signaling and PIP, and pharmacological inhibition of PIP may be useful to treat PIP positive tumors. PMID: 21809344
    28. Most basal-like breast carcinomas and unclassified triple-negative carcinomas are negative for mammaglobin and gross cystic disease fluid protein 15. PMID: 21411781
    29. expressed on a small subset of primary lung adenocarcinomas PMID: 19620839
    30. Intragenic amplification and formation of extrachromosomal small circular DNA molecules from the PIP gene on chromosome 7 in primary breast carcinomas PMID: 11992405
    31. different conformations and/or tissue-specific posttranslational modifications of the proteins, although their primary structure was identical by MS/MS analysis PMID: 12755619
    32. Forms a protein complex with PIG-F and is involved in the conversion of phosphatidylinositol glycans. PMID: 15632136
    33. The sensitivity of mammaglobin is equal or superior to that of GCDFP-15 for investigation of breast carcinoma. PMID: 18251583
    34. analysis of the novel complex formed between zinc alpha2-glycoprotein (ZAG) and prolactin-inducible protein (PIP) from human seminal plasma PMID: 18930737
    35. Both MGB1 and GCDFP-15 are specific markers for metastatic breast carcinomas in cell block fluid specimens (88 vs. 96%). PMID: 19217055
    36. importance of a regulatory subnetwork associated with PIP expression in which STAT5 appears as a potential transcriptional regulator PMID: 19262752
    37. PIP(alternate name GCDFP-15, gp17) is a secretory marker of apocrine differentiation in breast carcinoma. It is an aspartyl proteinase with specificity restricted for fibronectin. PMID: 10713110

    顯示更多

    收起更多

  • 亞細胞定位：
    Secreted.
  • 蛋白家族：
    PIP family
  • 組織特異性：
    Expressed in pathological conditions of the mammary gland and in several exocrine tissues, such as the lacrimal, salivary, and sweat glands.
  • 數(shù)據(jù)庫鏈接：

    HGNC: 8993

    OMIM: 176720

    KEGG: hsa:5304

    STRING: 9606.ENSP00000291009

    UniGene: Hs.99949